Prevalence of Mental Health Issues in Endurance Athletes.

Status Not yet recruiting

Clinical Trial Summary

Participation in endurance sports has been increasing over the last few decades and our aim of our exploratory descriptive survey study is therefore to examine mental health issues in endurance athletes (marathon runners, ultra endurance runners, triathletes), employing the IOC assessment tool, to provide information on mental health issues in this population. Secondary objects are to evaluate risk factors for mental health issues in endurance athletes (like exercise behaviour, competition behaviour, age, gender, medical issues)

Clinical Trial Description

This study is an exploratory descriptive survey study. The study protocol will be largely replicated from the IOC consensus paper and the questionnaires based according to SMHAT 1 with an athlete-specific screening tool (APSQ) and further eleven subsequent disorder-specific screening tools: Eleven disorder specific screening tools: 1. General Anxiety Disorder-7 (GAD-7): assesses the presence of symptoms of anxiety. 2. Patient Health Questionnaire-9 (PHQ-9): assesses the presence of symptoms of depression. 3. Athlete Sleep Screening Questionnaire (ASSQ): assesses the presence of sleep disturbance. 4. Alcohol Use Disorders Identification Test Consumption (AUDIT-C): assesses the presence of alcohol misuse. 5. Cutting Down, Annoyance by Criticism, Guilty Feeling, and Eye-openers Adapted to Include Drugs (CAGE-AID): assesses the presence of substance misuse, being slightly adapted for the SMHAT (no focus on alcohol use as already explored with the AUDIT-C; additional question to explore which substance was used). 6. Brief Eating Disorder in Athletes Questionnaire (BEDA-Q): assesses the presence of disordered eating. 7. ADHD 8. Bipolar disorder 9. PTSD 10. Gambling 11. Psychosis Additionally questions to assess exercise addiction will be used as it has been shown that exercise addiction may be particularly prevalent in endurance athletes. Further questions about age, gender, country of origin, training data, past medical history and medication will be asked as well as a few specific questions about there thoughts on mental health issues as per IOC consensus paper ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05768841
Study type	Observational
Source	Ultra Sports Science Foundation
Contact
Status	Not yet recruiting
Phase
Start date	March 2023
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04122482` - An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises	N/A
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Recruiting	`NCT04588883` - Strengthening Families Living With HIV in Kenya	N/A
Recruiting	`NCT04583891` - Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design	N/A
Recruiting	`NCT05554042` - Kintsugi Voice Device Study
Completed	`NCT02954250` - Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide	Early Phase 1
Recruiting	`NCT05647499` - Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study	N/A
Active, not recruiting	`NCT03980873` - Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach	N/A
Completed	`NCT04422327` - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome	Phase 1/Phase 2
Completed	`NCT05368155` - Chronic Pelvic Pain and Education Skills Training for Women Veterans	N/A
Completed	`NCT05455905` - Voice Biomarkers Predictive of Depression and Anxiety
Completed	`NCT03272516` - Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients	N/A
Not yet recruiting	`NCT05746767` - Supporting Peer Interactions to Expand Access to Digital Cognitive Behavioral Therapy for Spanish-speaking Patients	N/A
Not yet recruiting	`NCT05535101` - Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder	N/A
Recruiting	`NCT04418115` - Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?	N/A
Completed	`NCT04905524` - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)	N/A
Recruiting	`NCT03953118` - Azithromycin for Meibomian Gland Disease	Phase 4
Completed	`NCT03427372` - The Effect of Psychological State on Post Spinal Puncture Headache and Backache
Completed	`NCT04091633` - School Health Implementation Network: Eastern Mediterranean	N/A
Recruiting	`NCT04589052` - Identification of Anxiety and Depression in Adolescents/Young Adults (AYA) With Cancer

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.